“With this partnership, Sartorius continues to strengthen its leading position in the freeze-thaw market,” said Eva Lindskog, Head of Fluid Management Technologies at Sartorius
Sartorius and HOF Sonderanlagenbau have announced a partnership to integrate two HOF horizontal plate freeze-thaw units into Sartorius’ portfolio, offering customers a suite of compatible freeze-thaw equipment and consumables. The partnership is hoped to enable faster and easier implementation of frozen drug substance management platforms through improved validation and purchase support from a single supplier.
“With this partnership, Sartorius continues to strengthen its leading position in the freeze-thaw market,” said Eva Lindskog, Head of Fluid Management Technologies at Sartorius. “The combination of our robust Celsius single-use containers with market-leading freeze-thaw equipment from HOF will provide our customers with a simplified supply chain for improved management of drug substance.”
A key criterion in the drug substance freeze-thaw process is the ability to reliably control cooling and heating to prevent cryo-concentration. The companies say combining the Celsius consumables with HOF’s adjustable plate system provides predictability, robustness, and reproducibility.
Alexander Hof, CEO at HOF Sonderanlagenbau said: “Our customers that need to freeze during their processes are seeking the best available solutions. The unique combination of our reliable HOF freeze-thaw units and Sartorius’ proven single-use technology consumables portfolio will enable drug manufacturers to progress toward high quality, secure drug substance freezing and thawing for a safer future.”